Portfolio

Cryotherapeutics

Treatment of sustainable plaque in coronary arteries through our proprietary catheter based device.

Press Release CryoTherapeutics

 

 

Management

Dr. John Yianni

Press releases

Creathor Venture leads a Series B financing round of € 5.2 million in CryoTherapeutics

Creathor Venture, one of the leading European Venture Capital firms, leads a Series B financing round in CryoTherapeutics, the developer of a proprietary cryotherapy system for use in the treatment of coronary artery disease. The Life Science Start-up CryoTherapeutics receives at total of € 5.2 million in the…
Read

CryoTherapeutics GmbH completes an extension to its Series A Financing Round bringing the total to €6.5 million

CryoTherapeutics GmbH (CryoTherapeutics), the developer of a proprietary cryotherapy system for use in the treatment of coronary artery disease, announced today that it has completed an extension to its Series A financing round led by Peppermint Venture Partners (PVP) via its Charité Biomedical Fund with…
Read

CryoTherapeutics GmbH completes Second Closing of Series A Financing Round with a total volume of €3 million and adds Charité Biomedical Fund as investor

CryoTherapeutics GmbH (CryoTherapeutics), the developer of a proprietary cryotherapy system for use in the treatment of coronary artery disease, announced today that it has completed a second closing of its Series A financing round, with Peppermint VenturePartners (PVP) via its new Charité Biomedical Fund joining the…
Read

Info & Contact

Address

Gottfried-Hagen-Straße 60-62
51105 Köln

In portfolio

21. Dec 2009